Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | STAT6 | P42226 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 4/20 | 0.52 |
| ▸ | CYP11B1 | P15538 | 4/20 | 0.52 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.52 |
| ▸ | TNF | P01375 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7196401 | 0.75 | TDP1 (0.58) | TDP1SMN1; SMN2LMNASTAT6HTT | |
| SCHEMBL2489876 | 0.73 | TDP1 (0.56) | TDP1SMN1; SMN2LMNASTAT6HTT | |
| SCHEMBL145442 | 0.71 | TDP1 (0.54) | TDP1SMN1; SMN2LMNASTAT6HTT | |
| SCHEMBL460599 | 0.71 | TDP1 (0.54) | TDP1SMN1; SMN2LMNASTAT6HTT | |
| SCHEMBL39078 | 0.71 | TDP1 (0.54) | TDP1SMN1; SMN2LMNASTAT6HTT | |
| SCHEMBL9062626 | 0.71 | TDP1 (0.54) | TDP1SMN1; SMN2LMNASTAT6HTT | |
| SCHEMBL5399 | 0.71 | TDP1 (0.59) | TDP1SMN1; SMN2LMNAHTTCYP11B1 | |
| SCHEMBL8668369 | 0.71 | TDP1 (0.54) | TDP1SMN1; SMN2LMNASTAT6HTT | |
| SCHEMBL278161 | 0.71 | TDP1 (0.54) | TDP1SMN1; SMN2LMNASTAT6HTT | |
| SCHEMBL222667 | 0.71 | TDP1 (0.54) | TDP1SMN1; SMN2LMNASTAT6HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1810 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12263464-B2 | Method for in-situ synthesis of metal organic frameworks (MOFs), covalent organic frameworks (COFs) and zeolite imidazolate frameworks (ZIFs), and applications thereof | DESICCANT ROTORS INTERNATIONAL PRIVATE LIMITED (IN) | 2025-04-01 | — | — | US | claimed |
| WO-2023202368-A1 | NUCLEIC ACID ENCAPSULATION AND DECAPSULATION METHOD AND NUCLEIC ACID STORAGE MICRO-FLUIDIC CHIP | 南方科技大学 | 2023-10-26 | — | — | WO | claimed |
| CN-219239914-U | Anti-mite antibacterial deodorant moisture-conducting knitted fabric | 江苏品创纺织科技有限公司 | 2023-06-23 | — | — | CN | claimed |
| EP-3801880-A1 | METHOD FOR IN-SITU SYNTHESIS OF METAL ORGANIC FRAMEWORKS (MOFS), COVALENT ORGANIC FRAMEWORKS (COFS) AND ZEOLITE IMIDAZOLATE FRAMEWORKS (ZIFS), AND APPLICATIONS THEREOF | Desiccant Rotors International Private Ltd. (IN) | 2021-04-14 | — | — | EP | claimed |
| US-20210016245-A1 | METHOD FOR IN-SITU SYNTHESIS OF METAL ORGANIC FRAMEWORKS (MOFs), COVALENT ORGANIC FRAMEWORKS (COFs) AND ZEOLITE IMIDAZOLATE FRAMEWORKS (ZIFs), AND APPLICATIONS THEREOF | DESICCANT ROTORS INTERNATIONAL PRIVATE LIMITED (IN) | 2021-01-21 | — | — | US | claimed |
| EP-1564212-B1 | PROCESS AND INTERMEDIATES FOR OBTAINING 1-(1H-BENZIMIDAZOL-2-YL)-4-(PYRIMIDIN-2-YLAMINO)PIPERIDINE DERIVATIVES | RAGACTIVES SL (ES) | 2007-12-12 | — | — | EP | claimed |
| US-20050228006-A1 | Process and intermediates for obtaining 1-(1H-benzimidazol-2-YL)-4-(2-aminopyrimidine)piperidine derivatives | RAGACTIVES, S.L. | 2005-10-13 | — | — | US | claimed |
| EP-1564212-A1 | METHOD AND INTERMEDIA USED TO OBTAIN DERIVATIVES OF 1-(1H- BENZIMIDAZOLE-2-YL)-4-(2-AMINOPYRIMIDINE)PIPERIDINE | Ragactives, S.L. (ES) | 2005-08-17 | — | — | EP | claimed |
| US-12492185-B2 | Benzimidazole derivatives and their uses | TEIJIN PHARMA LIMITED (JP) | 2025-12-09 | — | — | US | disclosed |
| US-20250249431-A1 | METAL-ORGANIC FRAMEWORK FILM AND METHOD FOR PRODUCING SAME | MURATA MANUFACTURING CO., LTD. (JP) | 2025-08-07 | — | — | US | disclosed |
| EP-3952866-B1 | BENZIMIDAZOLE DERIVATIVES AND THEIR USES | TEIJIN PHARMA LTD (JP) | 2025-07-23 | — | — | EP | disclosed |
| CN-120018905-A | Metal organic structure film and method for producing same | 株式会社村田制作所 | 2025-05-16 | — | — | CN | disclosed |
| CN-113424016-B | Method for obtaining information on an organic solderability preservative on a printed circuit board | 德国艾托特克公司 | 2025-04-15 | — | — | CN | disclosed |
| US-12263464-B2 | Method for in-situ synthesis of metal organic frameworks (MOFs), covalent organic frameworks (COFs) and zeolite imidazolate frameworks (ZIFs), and applications thereof | DESICCANT ROTORS INTERNATIONAL PRIVATE LIMITED (IN) | 2025-04-01 | — | — | US | disclosed |
| US-4266018-A | SUBSTITUTED THIOUREA SENSITIZERS | FUJI PHOTO FILM CO., LTD. (JP) | 1981-05-05 | — | — | US | disclosed |
| US-4243739-A | HYDRAZIDE | FUJI PHOTO FILM CO., LTD. (JP) | 1981-01-06 | — | — | US | disclosed |
| US-4198240-A | SENSITIZERS COMPRISING THIOETHER AND THIOSULFONE COMPOUNDS | FUJI PHOTO FILM CO., LTD. (JP) | 1980-04-15 | — | — | US | disclosed |
| US-4152163-A | Silver halide photographic emulsion containing cyanine and hemicyanine sensitizing dyes | FUJI PHOTO FILM CO., LTD. (JP) | 1979-05-01 | — | — | US | disclosed |
| US-4110115-A | SILVER HALIDE, MEROCYANINE DYE | FUJI PHOTO FILM CO., LTD. (JP) | 1978-08-29 | — | — | US | disclosed |
| US-4040840-A | MEROCYANINE DYE HAVING ISOXAZOLE NUCLEUS AND PYRAZOLINE-5-ONE NUCLEUSN | FUJI PHOTO FILM CO., LTD. (JA) | 1977-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12492185-B2 | Benzimidazole derivatives and their uses | TRPC6, TRPC4, TRPC3 | TDP1 2023/4885SMN1; SMN2 3718/4885LMNA 2375/4885 |
| US-20050228006-A1 | Process and intermediates for obtaining 1-(1H-benzimidazol-2-YL)-4-(2-aminopyrimidine)piperidine derivatives | IL2, IL4, IL4I1 | TDP1 4142/4885SMN1; SMN2 3736/4885LMNA 3312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.